SERAFIM Trademark

Trademark Overview

On Monday, March 7, 2022, a trademark application was filed for SERAFIM with the United States Patent and Trademark Office. The USPTO has given the SERAFIM trademark a serial number of 97299100. The federal status of this trademark filing is REVIVED - AWAITING FURTHER ACTION as of Monday, September 16, 2024. This trademark is owned by Serafim LLC. The SERAFIM trademark is filed in the Pharmaceutical Products category with the following description:

Drug delivery agents in the form of sublingual liquid that facilitate the delivery of pharmaceutical preparations
serafim

General Information

Serial Number97299100
Word MarkSERAFIM
Filing DateMonday, March 7, 2022
Status616 - REVIVED - AWAITING FURTHER ACTION
Status DateMonday, September 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 19, 2023

Trademark Statements

Goods and ServicesDrug delivery agents in the form of sublingual liquid that facilitate the delivery of pharmaceutical preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 11, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSerafim LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSarasota, FL 34240
Party NameSerafim LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSarasota, FL 34240

Trademark Events

Event DateEvent Description
Friday, December 16, 2022ASSIGNED TO EXAMINER
Thursday, March 10, 2022NEW APPLICATION ENTERED
Friday, March 11, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 17, 2022NON-FINAL ACTION WRITTEN
Saturday, December 17, 2022NON-FINAL ACTION E-MAILED
Saturday, December 17, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, March 11, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, March 11, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, March 11, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 6, 2023NON-FINAL ACTION WRITTEN
Thursday, April 6, 2023NON-FINAL ACTION E-MAILED
Thursday, April 6, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 28, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 28, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 29, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 3, 2023FINAL REFUSAL WRITTEN
Friday, November 3, 2023FINAL REFUSAL E-MAILED
Friday, November 3, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, November 8, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, November 8, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, November 8, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, November 8, 2023EXAMINER'S AMENDMENT ENTERED
Monday, November 13, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 19, 2023PUBLISHED FOR OPPOSITION
Wednesday, November 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 13, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 16, 2024NOTICE OF REVIVAL - E-MAILED
Monday, September 16, 2024TEAS PETITION TO REVIVE RECEIVED
Monday, September 16, 2024ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 19, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, September 16, 2024PETITION TO REVIVE-GRANTED
Monday, September 16, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

serafim delivery facilitate pharmaceutical preparations liquid sublingual agents form drug